Is ILLUMINA, INC. (ILMN) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 13.4% / 30% | 8.6% / 30% | 4.5% / 30% | 0.92% / 5% | ✓ HALAL |
| DJIM | 13.4% / 33% | 8.6% / 33% | 4.5% / 33% | 0.92% / 5% | ✓ HALAL |
| MSCI | 38.4% / 33% | 24.6% / 33% | 12.9% / 33% | 0.92% / 5% | ✗ NOT HALAL |
| S&P | 13.4% / 33% | 8.6% / 33% | 4.5% / 33% | 0.92% / 5% | ✓ HALAL |
| FTSE | 38.4% / 33% | 24.6% / 33% | 12.9% / 50% | 0.92% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 68.2% | |
| Operating Margin | 19.7% | |
| Net Margin | 19.6% | |
| Return on Equity (ROE) | 33.4% | |
| Return on Assets (ROA) | 8.4% |
Cash Flow & Balance Sheet
| Operating Cash Flow | $1.1B |
| Free Cash Flow | $931M |
| Total Debt | $2.6B |
| Debt-to-Equity | 93.8 |
| Current Ratio | 2.1 |
| Total Assets | $6.6B |
Price & Trading
| Last Close | $124.40 |
| 50-Day MA | $129.38 |
| 200-Day MA | $114.04 |
| Avg Volume | 2.0M |
| Beta | 1.5 |
|
52-Week Range
$68.70
| |
About ILLUMINA, INC. (ILMN)
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. The company has a collaboration with Labcorp Holdings Inc. for the development of oncology treatments through applications of sequencing solutions across the healthcare ecosystem. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.
Purification Calculator
As a halal stock with 0.92% impermissible income, you need to purify your dividends.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is ILLUMINA, INC. (ILMN) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), ILLUMINA, INC. is Halal. The company passes all financial ratio thresholds for debt, cash, receivables, and impermissible income. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is ILLUMINA, INC.'s debt ratio?
ILLUMINA, INC.'s debt ratio is 13.4% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 38.4%.
Does ILLUMINA, INC. require dividend purification?
Yes, ILLUMINA, INC. has an impermissible income ratio of 0.92%, which means 0.92% of any dividends received should be donated to charity as purification. This is because a small portion of the company's revenue comes from non-Shariah-compliant sources.
What are ILLUMINA, INC.'s key financial metrics?
ILLUMINA, INC. has a market capitalization of $18.0B, trailing P/E ratio of 21.6, and revenue of $4.3B. The company maintains a gross margin of 68.2% and a net margin of 19.6%. Return on equity stands at 33.4%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.